Calendar - Page 2

Major Biopharma Catalysts on July’s FDA Calendar

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Merck & Co. Inc. (NYSE: MRK) shares retreated to start off the week after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted Keytruda for review ...
Read Full Story »

Biopharma Companies to Watch This Week

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Biopharma Companies to Watch This Week

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Biopharma Companies to Watch This Week and for the Rest of June

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

The Top Biopharma Catalysts Coming in May

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Is the FDA Expecting More Problems for Progenics?

Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) shares took a big step back on Friday after the firm announced that it received an update from the U.S. Food and Drug Administration (FDA). ...
Read Full Story »

Major Biopharma Catalysts and FDA Events to Look For in March

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

More Health Care Catalysts to Watch For by the End of February

Generally speaking, companies that reside within the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining ...
Read Full Story »

The Week of Economic Reports, the Stock Market Tank and Inflation Fears in the Coming Week

The week of February 9, 2018, was a wild ride in the stock markets, and despite the fear of rising rates, it wasn't really all that crazy in the bond ...
Read Full Story »

Major Biopharma Catalysts on February’s FDA Calendar

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

GE, Intel, Verizon and More Dow Earnings Coming This Week

Earnings reporting season for the fourth quarter is underway, and 24/7 Wall St. has put together a preview of the top Dow Jones Industrial Average companies due to report their ...
Read Full Story »

30 Big Biotech Events Coming in 2018

Over the past year, biotech companies have more or less kept pace with the markets, but they have the potential to break out in 2018. While they have been the ...
Read Full Story »

Top 10 Biopharma Events Kicking Off 2018

Biotechnology and pharmaceutical companies generally face a fair-to-great amount of risk based on the lengthy vetting process for their drug candidates, should a study come back negative or should a ...
Read Full Story »